No description available.

Diss. (sammanfattning) Stockholm : Karol. inst. / Härtill 5 uppsatser.

Submitted by André Chamelete null (andre_ecco@hotmail.com) on 2016-02-12T14:02:00Z No. of bitstreams: 1 Dissertação de Mestrado - FINAL.pdf: 663322 bytes, checksum: 5ca648d67a3a798d08f9c68653ac3ca2 (MD5) / Approved for entry into archive by Sandra Manzano de Almeida (smanzano@marilia.unesp.br) on 2016-02-12T17:20:57Z (GMT) No. of bitstreams: 1 chamelete_a_me_sjrp.pdf: 663322 bytes, checksum: 5ca648d67a3a798d08f9c68653ac3ca2 (MD5) / Made available in DSpace on 2016-02-12T17:20:57Z (GMT). No. of bitstreams: 1 chamelete_a_me_sjrp.pdf: 663322 bytes, checksum: 5ca648d67a3a798d08f9c68653ac3ca2 (MD5) Previous issue date: 2016-01-25 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / O BaP é um contaminante ambiental capaz de causar inflamação e desregulação de vias celulares. Pela ação da CYP1a1 e CYP1b1, é convertido a metabólitos mais reativos. A literatura mostra que o BaP aumenta a expressão de algumas citocinas próinflamatórias, como a IL-1, porém, são bem contraditórios os relatos sobre o efeito do BaP no cFOS, o qual apresenta papel importante na proliferação, na formação de tumores e, possivelmente, na inflamação. O objetivo deste estudo foi de elucidar a participação do receptor purinérgico P2X7 sobre a expressão dos genes IL-1 e cFOS, durante exposição ao BaP. Foi empregado as técnicas de qPCR para quantificação de expressão gênica, e testes de correlação e regressão entre IL-1 e cFOS. A exposição ao BaP induziu a expressão dos dois genes, além das enzimas do seu metabolismo. Quando bloqueado o receptor P2X7, além de uma menor indução das CYPs, os níveis de IL-1 e cFOS caíram abaixo dos níveis controle, sugerindo a participação do P2X7. Os testes de correlação e regressão mostraram uma relação forte direta entre IL-1 e cFOS, reforçando o papel do cFOS na inflamação. / BaP is an environmental contaminant capable to cause inflammation and impair cellular pathways. CYP1a1 and CYP1b1 convert it to more reactive metabolites. Studies show that BaP enhances some proinflammatory citokines expression, like IL-1, yet reports about BaP affecting cFOS, which plays important role in proliferation, tumor formation and inflammation, are controversial. This work aimed to elucidate whether P2X7 purinergic receptor plays a role in IL-1 and cFOS expression during BaP exposure. We applied qPCR techniques to quantify gene expression, correlation and regression assays. Our results showed that BaP raised both IL-1 and cFOS genes expression, besides CYPs ones. Morevoer, when blocking P2X7 receptor, IL-1 and cFOS expression dropped under normal levels, which suggest P2X7 participation, in addition to a smaller enzymes induction. Correlation and regression assays exhibited a strong straight relationship between IL-1 and cFOS expression, reinforcing the role of cFOS in inflammation.

Reconnu par le Centre international de recherche sur le cancer (CIRC) comme cancérigène chez l’être humain, le benzo[a]pyrène (BaP) est un des hydrocarbures aromatiques polycycliques (HAP) les plus étudiés. Souvent rencontrés dans de nombreux milieux de travail, les HAP sont un groupe de polluants omniprésents dans l’environnement, formé par des processus de combustion incomplets. Bien que le BaP présente un risque élevé pour la santé des travailleurs, il n’existe aucun biomarqueur spécifique au composé permettant le suivi et la surveillance d’exposition au BaP dans un lieu de travail. Le 3-hydroxybenzo[a]pyrène (3-OHBaP) est le métabolite du BaP le plus développé comme biomarqueur. Ce métabolite est principalement excrété dans les fèces, ainsi qu’une quantité infime dans l’urine, ce qui le rend difficile à mesurer. De plus, le 3-OHBaP montre une certaine rétention rénale, un facteur qui rend plus compliqué son utilisation en tant que biomarqueur car il oblige de prendre plusieurs critères en compte dans l’analyse de sa cinétique temporelle. Par ailleurs, le 1-hydroxypyrène (1-OHP) est un métabolite urinaire du pyrène souvent utilisé comme biomarqueur d’exposition aux HAP. Neanmoins, il s’agit du métabolite d’un HAP non-cancérigène et par conséquent sa capacité de démontrer le risque de cancer associé à une exposition donnée est faible. Ce mémoire visait à détecter et à évaluer l'exposition au BaP en suivant ses métabolites urinaires: le 4,5-dihydrodiol-benzo[a]pyrène et le 7,8-dihydrodiol-benzo[a]pyrène (le 4,5-diolBaP et le 7,8-diolBaP; les diolBaP). L’évaluation du 4,5-diolBaP et du 7,8-diolBaP s’est déroulée dans deux études: La première étude, surnommée « l’expérience du shampooing », portait sur un volontaire qui s’est exposé aux HAP dans un environnement contrôlé en utilisant un shampooing à base de goudron de houille. Cette étude a été conçue afin d’évaluer l'évolution temporelle du 7,8-diolBaP chez l'homme et de vérifier son potentiel en tant que biomarqueur d'exposition par comparaison avec le 1-OHP dans le même cadre expérimental. Elle a été réalisée avec deux expériences. La première portait sur une seule exposition et la seconde sur une exposition multiple. La deuxième étude, surnommée « l’étude des travailleurs », reposait sur une analyse comparative du 4,5-diolBaP, du 7,8-diolBaP, du 1-OHP et du 3-OHBaP dans un milieu de travail. Cette étude avait pour objectif d’évaluer les compétences des diolBaP dans un contexte réel à côté des biomarqueurs établis d'exposition au BaP et aux HAP. Cinq travailleurs d'une usine de production d'anodes en carbone ont accepté de participer à cette étude. Dans le cadre de ces deux études, les échantillons d'urine étaient analysés par la chromatographie en phase liquide à ultra-haute performance (UHPLC) couplée à la fluorescence. « L’expérience du shampooing » : L’expérience de l’exposition unique et celle de l’exposition multiple ont révélé une élimination de façon mono-exponentielle du 7,8-diolBaP, identique à celle du 1-OHP, avec des concentrations dans le même ordre de grandeur. Nous avons également confirmé un taux d’élimination plus rapide pour le 1-OHP en regardant ses pics. Le 7,8-diolBaP augmente en valeur maximale après chaque exposition, et cette découverte a mis en évidence une accumulation tout au long de la semaine, alors que pour le 1-OHP, le deuxième pic est plus grand, mais le troisième est plus petit, montrant ainsi moins d'accumulation pendant la même période temporelle. « L’étude des travailleurs »: Selon les résultats, la méthode analytique utilisée était incapable de discerner correctement le 4,5-diolBaP des autres contaminants urinaires éluant pendant le même temps de rétention. Le 7,8-diolBaP, quant à lui, élue à des concentrations urinaires d'un ordre de grandeur similaire au 1-OHP tel que vu chez tous les travailleurs évalués. Chez certains travailleurs, la concentration urinaire du 7,8-diolBaP était toujours plus élevée avant le début d'un quart de travail avec l'élimination qui avait lieu pendant le quart de travail pour fournir une valeur de concentration inférieure à la fin du quart de travail. Cependant, la concentration du 1-OHP a eu une hausse immédiate avec l'exposition, culminant à la fin de chaque quart de travail. Pour les autres travailleurs, les concentrations du 7,8-diolBaP et du 1-OHP étaient systématiquement plus élevées à la fin du quart de travail. Il est probable que ces variations indiquent les différentes voies d'exposition. Le présent mémoire a montré le potentiel du 7,8-diolBaP en tant que biomarqueur d'exposition spécifique au BaP et par conséquent, il fournit un point de départ pour explorer la quantification du lien entre l'exposition au BaP et ses effets néfastes sur la santé de l'être humain. L’utilisation de la spectrométrie de masse est nécessaire à confirmer l’identité des diolBaP avant d'aller de l'avant. / Benzo[a]pyrene (BaP) is one of the more commonly studied polycyclic aromatic hydrocarbons (PAHs), a group of omnipresent pollutants in the environment formed through incomplete combustion processes. It is listed as a confirmed carcinogen to human beings by the International Agency for Research on Cancer (IARC) and is highly present in many workplaces. Although presenting a significant health risk to workers, there are currently no convenient compound-specific biomarkers that enable the tracking and monitoring of occupational exposure to BaP. 3-Hydroxybenzo[a]pyrene (3-OHBaP) is the most developed, as a biomarker, amongst the metabolites of BaP. It’s mostly excreted with the faeces, presenting in trace amounts in urine, which makes it difficult to measure; it is also demonstrates renal retention, which adds a layer of complexity in its use as a biomarker because there are many factors to take into consideration when looking at its kinetic time course. 1-Hydroxypyrene (1-OHP), in the other hand, is a urinary metabolite of pyrene that serves as a good representative of PAH presence. It is, however, the metabolite of a non-carcinogenic PAH, and is not fully capable of representing the cancer risk posed in a given scenario. This thesis sought to detect and assess BaP exposure through tracking its urinary metabolites: 4,5-dihydrodiol-benzo[a]pyrene and 7,8-dihydrodiol-benzo[a]pyrene (4,5-diolBaP and 7,8-diolBaP; diolBaPs). 4,5-DiolBaP and 7,8-diolBaP were evaluated through two studies: The first study, the “shampoo experiment”, featured a volunteer who self-exposed to PAHs in a controlled setting by using a coal-tar-based shampoo. The study consisted of two experiments. The first focused on a single exposure and the second on multiple exposures. This study was set to evaluate the time course of 7,8-diolBaP in humans and verifying its potential as a biomarker of exposure through a comparison with 1-OHP in the same experimental framework. The second study consisted of a comparative analysis of 4,5-diolBaP, 7,8-diolBaP, 1-OHP and 3-OHBaP in an occupational setting, evaluating the competency of the diolBaPs in a real-world setting alongside established biomarkers of BaP and PAH exposure. Five workers at a carbon anode production plant volunteered to participate in this study. For both of these studies, the urine samples were analysed by ultra-high-pressure liquid chromatography (UHPLC) coupled with fluorescence. “Shampoo Experiment”: The single and multiple exposures revealed a monoexponential elimination on the part of 7,8-diolBaP, identical to 1-OHP, with similar magnitudes of concentration. 1-OHP was also confirmed to undergo a more rapid elimination from the system, where after each exposure for 7,8-diolBaP, the ensuing peak value is higher. This finding demonstrated evidence of accumulation of 7,8-diolBaP throughout the week, whereas with 1-OHP, the second peak is larger, then the third one is smaller, thus showing less accumulation over the same time frame. “Worker Study”: The results showed that the analytical method used was unable to properly discern 4,5-diolBaP from other urinary contaminants eluting during the same retention time. 7,8-DiolBaP, on the other hand, eluted at urinary concentrations that were a similar order of magnitude to 1-OHP, as can be seen in all of the workers evaluated. For some workers, the urinary concentration of 7,8-diolBaP was consistently at its peak prior to the start of a shift and elimination took place during the shift, to provide a lower concentration value at the end of the shift. With 1-OHP, the rise was immediate with exposure, peaking at the end of every shift. For other workers, both 7,8-diolBaP and 1-OHP are consistently higher at the end of the shift. These variations are likely to indicate different routes of exposure. This thesis showed the potential use of 7,8-diolBaP as a compound-specific biomarker of exposure for BaP and thus provides a starting point in exploring the quantification of BaP exposure and negative health effects in humans. Confirmation of the compound’s identity is needed through the use of mass spectrometry.

Le Benzo(a)pyrène (B(a)P) est un hydrocarbure polycyclique aromatique (HAP). Il provient de la combustion incomplète de matériaux organiques, de la circulation automobile, du chauffage domestique, du tabagisme et de l'alimentation. Il est métabolisé principalement dans le foie. Il existe pour le B(a)P trois voies métaboliques : la monoxygenation, la voie des peroxydases et la voie des quinones. Une fois le B(a)P biotransformé, ses métabolites sont conjugués principalement au glutathion, au PAPS (3'-phosphoadenosine-5'-phosphosulfate) et l'UDPGA (acide uridine 5'-diphosphoglucuronique). On connaît le pouvoir cancérogène et génotoxique du B(a)P, cependant, certains médicaments pourraient interférer dans une ou plusieurs voies métaboliques utilisées par ce dernier, voire même dans le processus de réparation de l'ADN lors de la formation d'adduits ADN-BPDE (BPDE : benzo(a)pyrène diol époxyde) chez l'humain. Les connaissances actuelles concernant le potentiel d'interactions des médicaments sur le pouvoir cancérogène du B(a)P restent minimes. Très peu d'information existe sur les interactions métaboliques entre le B(a)P et médicaments pouvant affecter le taux de formation des adduits à l'ADN. Les objectifs de cette étude consistent à mettre au point une méthode analytique spécifique pour mesurer le taux de formation d'adduits ADN-B(a)P et à l'appliquer pour identifier des médicaments susceptibles d'interférer dans ce processus. Pour cela, on incube des lignées cancéreuses d'hépatocytes humains (HepG2) pendant 6 h en présence de 30 µM de 7-10 14C B(a)P (doublement marqué en C7 et en C10) seul ou en présence du médicament à tester (la concentration du médicament = 10 x la concentration maximale plasmatique thérapeutique). La gamme de médicaments sélectionnée a un large spectre de consommation dans le monde. Cette gamme est composée de : l'acétaminophène, l'ibuprofène, l'acide acétylsalicylique, l'acide méfénamique, le naproxène, l'acide valproïque, le carbamazépine, le gliclazide et la théophylline. La mesure du taux de formation d'adduits à l'ADN s'est faite par détection radiométrique sur de l'ADN isolée. On a aussi comparé les taux d'adduits formés dans les échantillons témoins (exposé seulement au B(a)P) à ceux formés en présence de médicaments. A l'aide de la méthodologie développée, nous avons observé que pour certains passages de culture cellulaires (HepG2), l'ibuprofène augmente substantiellement le taux de formation d'adduit à l'ADN du B(a)P (jusqu'à 2.3 fois), alors que le naproxène et l'acide méfénamique ont plutôt un effet protecteur (jusqu'à 0.5 fois pour le naproxène et 0.7 fois pour le l'acide méfénamique). Ces résultats suggèrent que la consommation chronique de certains anti-inflammatoires non stéroïdiens pourrait augmenter (ibuprofène) ou diminuer (naproxène et acide méfénamique) le risque carcinogène. Ceci est la première étude qui se consacre à déterminer les interactions du B(a)P avec neuf médicaments. Des études plus poussées sur la cinétique de réparation de l'ADN et sur la caractérisation des différentes interactions aboutiraient à une meilleure évaluation du risque toxicologique du B(a)P. ______________________________________________________________________________ MOTS-CLÉS DE L’AUTEUR : Bezopyrene, interactions, adduits, AINS.

Arbuscular mycorrhizal fungi (AMF) can play an important role in the phytoremediation of petroleum hydrocarbon (PH)-contaminated soil. However, little is known about the effects of AMF in combination with biostimulation via fertilization or bioaugmentation with hydrocarbonoclastic microorganisms, during phytoremediation of PH in soils. This research evaluated the influence of the AMF Glomus intraradices and inorganic fertilization on growth and physiological responses of Lolium multiflorum Lam. cv. Passarel Plus during phytoremediation of soil contaminated with Arabian medium crude oil (ACO). Also determined was the interaction of AMF with the hydrocarbonoclastic bacterium, Sphingomonas paucimobilis EPA505 (Sp), and the filamentous fungus, Cunninghamella echinulata var. elegans ATCC-36112 (Ce), on growth and selected physiological responses of L. multiflorum during phytoremediation of soil contaminated with benzo[a]pyrene (BaP) or ACO. This research provides evidence that AMF enhance the phytoremediation of petroleum hydrocarbons in soils when inoculated with L. multiflorum. The concentration of petroleum hydrocarbons in soil was a determining factor of potential benefits of AMF on L. multiflorum. Low (3000 mg·kg-1) or high (15000 mg·kg-1) concentrations of ACO resulted in limited benefits of AMF on plant growth, physiology, and degradation of ACO in soil. However, when plants were exposed to an intermediate ACO concentration in soil (6000 mg·kg-1), AMF plants had enhanced growth, physiological responses, and greater ACO-degradation than non-AMF plants. The AMF symbiosis in roots of plants was observed at all concentrations of ACO-contaminated soil. This research is one of the first reports demonstrating the benefits of AMF on the degradation of benzo[a]pyrene or ACO, alone or in combination, with the hydrocarbonoclastic microorganisms. Thus, AMF resulted in a beneficial synergism with the hydrocarbonoclastic microorganisms, particularly during ACO-degradation in the rhizosphere of L. multiflorum. Hydrocarbonoclastic microorganisms had no negative effects on AMF colonization.

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental contaminants. There are numerous studies reporting developmental cardiac toxicity in multiple fish species due to PAH exposure. However, there are relatively few instances where the effects of acute PAH exposure in adult fish have been characterized. Furthermore, the majority of experiments comparing PAH toxicity with exposure route in adult fish focus on CYP1A gene expression or enzyme activity, while there is a lack of information about the possible pathophysiological effects. Therefore, the overall objective of this thesis was to characterize the sublethal effects of benzo[a]pyrene (BaP), a prototypical PAH, on adult zebrafish (Danio rerio) cardiorespiratory function and fitness following acute exposure by two different routes. In the first experiment, adult zebrafish were intraperitoneally (i.p.) injected twice (one injection/24 hr) with increasing concentrations of BaP (0.1, 10, and 1000 μg/kg) and compared to corresponding dimethylsulfoxide (DMSO) controls. In a second set of experiments, adult zebrafish were aqueously exposed to BaP (static, renewal at 24 hr; 16.2 and 162 μg/L) and compared to DMSO controls. Following 48 hr exposure, one group of fish (n=10/treatment group) were subjected to swimming performance tests to assess critical swimming speed (Ucrit), oxygen consumption rate (MO2), cost of transport (COT), standard metabolic rate (SMR), active metabolic rate (AMR), and factorial aerobic scope (F-AS). Another group of fish (n=12/treatment group) were subjected to echocardiography following 48 hr BaP exposure to evaluate cardiac function. Following echocardiography analysis, samples were collected for parent compound (BaP) body burden and CYP1A mRNA induction analysis. 48 hr BaP injection resulted in significant sublethal effects on adult zebrafish cardiorespiratory function. Oxygen consumption (MO2) was increased at three swimming speeds in injected BaP groups compared to control. In contrast, aqueously BaP-exposed fish showed increased MO2 only at the single lowest swim speed. COT was also similarly increased for both exposure routes. SMR was elevated with both exposure routes, while AMR remained unchanged. This resulted in a significant decrease in F-AS for all treatment groups compared to corresponding controls with both exposure routes. Cardiac function was significantly affected by both routes of BaP exposure. Ventricular heart rate was significantly decreased in BaP-exposed fish, both injected and aqueously-exposed. However, stroke volume was decreased only in fish aqueously exposed to BaP, which resulted in significantly reduced cardiac output with that exposure route. In contrast, the ratio of atrial to ventricular heart rate (AV ratio) was increased only in fish i.p. injected with BaP, indicating the possibility of cardiac arrhythmias occurring. Analysis of BaP body burdens in fish tissue allowed for identification of an overlapping dose group between exposure routes, through which comparisons of cardiotoxicity were then made. This comparison revealed slight differences in cardiotoxicity between exposure routes. BaP-injected fish suffered from more severe bradycardia than aqueously exposed fish. Furthermore, cytochrome P4501A (CYP1A) mRNA levels in liver and heart tissue showed more significant increases in injected fish, while skeletal muscle CYP1A was increased only following aqueous exposure. In conclusion, acute BaP exposure caused metabolic alterations and impaired cardiorespiratory function in adult zebrafish regardless of exposure route. Interestingly, the primary mechanism behind these effects appeared to differ slightly with exposure route. These results suggest that acute BaP exposure may have negative effects on adult fish survivability in the environment. Overall, this work provides valuable insight into the pathophysiogical consequences of acute PAH exposure in adult stage fish.

Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous contaminants entering the environment from both natural and anthropogenic sources. The main anthropogenic sources are processes for the production of electricity and thermal energy, waste incineration, road traffic and motor vehicles, aircraft, boats, steam and diesel-electric locomotives and some industrial technologies. Besides these main sources there are still a number of others, less important, e.g. working with hot tar, asphalt pavement wear and tire during vehicle operation, coking plants, plants for processing of oil and some metals plants. An indispensable source in the cities as domestic solid fuel burning furnaces. Although Hradec Králové do not belong to the cities with extreme levels of contaminants in the air, according to the Czech Hydrometeorological Institute, the levels of benzo(a)pyrene in the case of annual average concentrations exceeding the maximum allowable concentrations occurred here in 2013. While air quality is monitored regularly, the PAHs contents in soils and vegetation are not so. In our simple single experiment, we decided to assess the level of contamination of soil PAHs in the land of Hradec Kralove. It was collected 86 soil samples, in which were determined contents of 16 PAHs. Further, mushroom fruit samples that were found in the individual sampling points were analyzed. The results showed large variability of PAHs content in the city, but did not indicate significant levels of contamination. The sum of all the determined PAU does not exceed the permissible value of the contents of these elements in soils. However, in several cases exceeding the maximum allowable content in soils with different PAHs, especially fluoranthene, anthracene and chrysene. Linear correlation analysis showed that the levels of all monitored PAHs are close correlations, which indicates that the entire spectre of PAHs in this case always originates from the same source. The PAH contents in mushrooms were in most cases below the detection limit of the determination, only rarely the detectable contents of individual PAHs were found (Cylocybe gambosa, Agaricus arvensis). We can speculate about the limited ability of fungi to accumulate PAHs or their ability to degrade these substances.

Le Benzo(a)pyrène (BaP), appartenant à la famille des hydrocarbures aromatiques polycycliques (HAP) est cancérigène pour l’homme. Nous avons développé une approche protéomique quantitative nanoLC-MS/MS label-free pour identifier des biomarqueurs liés à l’exposition au BaP dans le sécrétome des cellules hépatiques humaines exposées au BaP vs. des cellules non exposées et exposées au Benzo(e)pyrène (BeP). Le BeP, agent non classifié comme cancérigène pour l’homme, est choisi comme contrôle négatif afin de distinguer les protéines spécifiques du BaP de celles des HAP. 847 protéines ont été identifiées et quantifiées, et 55 ont été fortement surexprimées avec un ratio supérieur à 5 : la plupart de ces protéinessurexprimées sont précoces et liées au cancer. Une validation ultérieure de l'expression de ces protéines dans le plasma de la population exposée au BaP aidera dans le développement de biomarqueurs qui permettront d'améliorer la détection précoce, le pronostic et prévention. / Benzo(a)pyrene (BaP) belongs to a class of polycyclic aromatic hydrocarbon and is reported as a potent human carcinogen. We performed a nanoLC-MS/MS-based label-free quantitative proteomics approach to identify potential biomarkers of exposure in the secretome of BaPtreated vs. non-treated and Benzo(e)pyrene (BeP)-treated human hepatoma cell line HepG2.BeP-treated cells were chosen as a negative control to distinguish the BaP-specific from the HAP-specific regulated proteins: BeP is not classifiable as to its carcinogenicity to humans. 847 proteins have been identified and quantified and 55 proteins were seen as being highly upregulated with a fold change of at least 5. Most of these up-regulated proteins were focused incancer-related activities. Further validation of expression of these proteins in the plasma of BaP-exposed population will assist in the development of biomarkers that will greatly improve early detection, prognosis, prediction of treatment response and prevention.

Abstract The tumour suppressor gene TP53 is the most commonly mutated gene in human cancers. The protein it codes, p53, becomes activated as a response to stress signals. When activated, p53 binds to DNA and affects the transcription of its target genes. They then cause cell cycle arrest, DNA repair and/or induction of programmed cell death, thus preventing mutations and cancer. Specific mutations in TP53 are associated with exposure to certain carcinogens, such as polycyclic aromatic hydrocarbons (PAHs). These environmental chemical carcinogens are formed through incomplete combustion of organic material. Benzo(a)pyrene (BP) is commonly used as a model compound for PAH carcinogenesis. BP causes accumulation of p53, but the mechanism of accumulation is not known. The aim of this study was to gain more insight into the p53 protein in the first phases of PAH carcinogenesis in vivo in mouse, using BP as the model compound. Mice from the inbred C57BL/6 strain were treated topically or intraperitoneally with BP or were exposed to cigarette smoke inhalation. The amount of p53 protein was studied by immunoblotting, immunohistochemistry and immuno electron microscopy, and the mdm2, p21 and p19ARF proteins were studied by immunoblotting. The binding of BP to DNA was measured by synchronous fluorescence spectrophotometry. The p53 protein was induced in vivo in skin and lung after BP treatment and in lung after cigarette smoke treatment. An increase in p53 was associated with an increase in the amount of BP-DNA adducts. In skin, the induction of p53 was accompanied by induction of the p21 and mdm2 proteins, which are transcriptional targets of p53. This indicates that the in vivo induced p53 is a wild-type protein and functional. In lungs, the induction of p53 was accompanied by a decrease of mdm2 and an increase of p19ARF. These results confirm that BP is metabolized and binds to DNA in mouse tissues and indicate that BP-DNA adducts are the trigger for p53 protein induction. The in vivo regulation of the p53 protein is different in different tissues of C57BL/6 mouse.